ArticleJTCVS open2025
Limited versus extended arch replacement during acute type A aortic dissection repair for nonsyndromic patients with dissected arch vessels.
Article in JTCVS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: It remains controversial whether extended arch (EA) replacement should be indicated for arch vessel dissection (AVD) during acute type A aortic dissection (ATAAD) repair. We aimed to evaluate the impact of hemiarch versus EA replacement on clinical outcomes in nonsyndromic patients with AVD undergoing ATAAD repair. Methods: We enrolled nonsyndromic patients with AVD but without cerebral or upper limb malperfusion who underwent ATAAD repair at our institution between 1999 and 2022. Clinical outcomes were analyzed after adjustment with inverse probability of treatment weighting (IPTW). The association of adverse events with death was assessed using time-dependent Cox regression models. Results: Among the 181 patients in the study cohort, 117 underwent hemiarch replacement (64.6%) and 64 underwent EA replacement (35.4%). Operative mortality occurred in 9 patients (7.7%) in the hemiarch group and 7 patients (10.9%) in the EA group ( Conclusions: In nonsyndromic patients with AVD undergoing ATAAD repair, EA replacement was associated with an increased risk of stroke, whereas hemiarch replacement did not lead to increased aorta reinterventions, suggesting that hemiarch replacement is an acceptable option for repairing ATAAD in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.